Segment Information (Tables)

9 Months Ended

Mar. 31, 2013

Nine Months Ended March 31, 2013 and 2012:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2013
Net sales	$	92,559	$	142,169	$	141,847	$	-		$	376,575
Gross profit		28,062		25,429		20,249		-			73,740
Income (loss) before income taxes		12,760		12,432		8,391		(7,276	)		26,307

2012
Net sales	$	78,243	$	121,537	$	133,659	$	-		$	333,439
Gross profit		22,860		18,654		19,804		-			61,318
Income (loss) before income taxes		9,836		5,839		7,940		(4,164	)		19,451

Three Months Ended March 31, 2013 and 2012:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2013
Net sales	$	36,299	$	61,776	$	52,796	$	-		$	150,871
Gross profit		11,052		13,382		7,093		-			31,527
Income (loss) before income taxes		5,389		8,794		3,010		(5,606	)		11,587

2012
Net sales	$	28,182	$	40,580	$	52,653	$	-		$	121,415
Gross profit		7,798		6,185		8,172		-			22,155
Income (loss) before income taxes		2,990		1,890		3,849		(1,181	)		7,548

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details